Genomics

Dataset Information

0

Chromatin accessibility contributes to Candida albicans adaptation to echinocandins


ABSTRACT: Infections by the major opportunistic pathogen of human Candida albicans are commonly treated with echinocandin (ECN) drugs. However, C. albicans can adapt to grow in the presence of certain amounts of ECNs. Prior studies by several laboratories have defined multiple genes, as well as mechanisms involving induced aneuploidy, that can govern this. Still, mechanisms of ECN adaptation are not fully understood. Here, we use genome-wide profiling of chromatin accessibility by ATAC-seq to determine if ECN adaptation is reflected in changes in the chromatin landscape in the absence of aneuploidy. We find that drug adaptation is coupled with multiple changes in chromatin accessibility genome-wide, which occur predominantly in gene promoter regions. Areas of increased accessibilities in promoters are enriched with the binding motifs for at least two types of transcription factors: zipfinger and b-zipfinger. We also find that chromatin changes are often associated with differentially-expressed genes including genes with functions relevant to the ECN-adapted phenotype, such as cell wall biosynthesis. Consistent with this, we find that the cell wall is remodeled in ECN-adapted mutants, with chitin up and glucan down and increased cell surface exposure. Full understanding of ECN adaptation processes is of critical importance for prevention of clinical resistance.

ORGANISM(S): Candida albicans SC5314

PROVIDER: GSE284528 | GEO | 2025/03/11

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2010-12-10 | E-GEOD-25891 | biostudies-arrayexpress
2010-12-10 | GSE25891 | GEO
| PRJNA1199474 | ENA
| PRJNA896937 | ENA
2024-08-12 | GSE273576 | GEO
2011-10-01 | GSE20509 | GEO
2010-11-05 | GSE18819 | GEO
2019-10-16 | GSE130948 | GEO
2019-12-04 | GSE140563 | GEO
2019-05-23 | GSE122037 | GEO